Wire Stories

FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)

— 12 Weeks of Treatment with EOHILIA May Address Significant Unmet Needs of Patients 11…

Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on ReActiv8® Restorative Neurostimulation SystemTM

U.S. patients implanted with ReActiv8 now eligible for full-body MRI scans DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings…

TAGTHAi Joins Forces at Ratchaprasong by Receiving Privileges From Partners, Further Developing the Power of Faith Tourism, Attracting Worldwide Tourists to Enhance Luck for Chinese New Year 2024

  BANGKOK--(BUSINESS WIRE)--#TAGTHAi--TAGTHAi, Thailand's Official Travel Platform, joins forces with Ratchaprasong Square Trade Association (RSTA)…

Cargill SustainConnectâ„¢ to meet rising demand for sustainable canola & open new revenue streams for Australian canola growers

SYDNEY--(BUSINESS WIRE)--Cargill is introducing a sustainable agriculture program to help Australian canola growers connect with…

Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows

NEW YORK & BRISBANE, Australia--(BUSINESS WIRE)--Radformation, a global pioneer in radiation oncology software solutions, is…

Karooooo Share Repurchase

SINGAPORE--(BUSINESS WIRE)--Karooooo Limited (“Karooooo”) announces share repurchase by the Company. VOLUNTARY DISCLOSURE: SHARE REPURCHASE At…

Shionogi Announces New Phase 3 Data Showing Early Resolution of Many Common COVID-19 Symptoms in JAMA Network Open

Publication Includes Results of the Phase 3 Trial Evaluating Once-Daily Ensitrelvir in Asia Trial Met…